英文名稱 | ABT-494(Upadacitinib) Free base |
---|---|
中文名稱 | 烏帕替尼 |
CAS號 | 1310726-60-3 |
分子式 | C??H??F?N?O |
分子量 | 380.37 |
外觀 | White to yellow powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | ABT-494(Upadacitinib) Free base |
---|---|
中文名稱 | 烏帕替尼 |
CAS號 | 1310726-60-3 |
分子式 | C??H??F?N?O |
分子量 | 380.37 |
外觀 | White to yellow powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis. ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 demonstrates efficacy in rat arthritis models. Preliminary evidence suggests that compared to tofacitinib, ABT-494 may spare Jak2 and Jak3 dependent signaling.